Annual Revenue
$11.76 M
+$9.82 M+505.77%
31 December 2023
Summary:
Verve Therapeutics annual revenue is currently $11.76 million, with the most recent change of +$9.82 million (+505.77%) on 31 December 2023. VERV annual revenue is now at all-time high.VERV Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$6.87 M
+$173.00 K+2.59%
30 September 2024
Summary:
Verve Therapeutics quarterly revenue is currently $6.87 million, with the most recent change of +$173.00 thousand (+2.59%) on 30 September 2024. Over the past year, it has increased by +$3.75 million (+120.24%). VERV quarterly revenue is now at all-time high.VERV Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$24.40 M
+$3.75 M+18.15%
30 September 2024
Summary:
Verve Therapeutics TTM revenue is currently $24.40 million, with the most recent change of +$3.75 million (+18.15%) on 30 September 2024. Over the past year, it has increased by +$16.77 million (+219.91%). VERV TTM revenue is now at all-time high.VERV TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +505.8% | +120.2% | +219.9% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
VERV Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +505.8% | at high | +639.0% | at high | +2526.1% |
| 5 y | 5 years | at high | +505.8% | at high | +639.0% | at high | +2526.1% |
| alltime | all time | at high | +505.8% | at high | +639.0% | at high | +2526.1% |
Verve Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.87 M(+2.6%) | $24.40 M(+18.2%) |
| June 2024 | - | $6.69 M(+17.5%) | $20.65 M(+28.7%) |
| Mar 2024 | - | $5.70 M(+10.7%) | $16.05 M(+36.5%) |
| Dec 2023 | $11.76 M | $5.14 M(+65.0%) | $11.76 M(+54.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $3.12 M(+48.9%) | $7.63 M(+40.2%) |
| June 2023 | - | $2.09 M(+49.1%) | $5.44 M(+62.6%) |
| Mar 2023 | - | $1.40 M(+38.7%) | $3.35 M(+72.3%) |
| Dec 2022 | $1.94 M | $1.01 M(+8.9%) | $1.94 M(+108.9%) |
| Sept 2022 | - | $929.00 K | $929.00 K |
FAQ
- What is Verve Therapeutics annual revenue?
- What is the all time high annual revenue for Verve Therapeutics?
- What is Verve Therapeutics annual revenue year-on-year change?
- What is Verve Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Verve Therapeutics?
- What is Verve Therapeutics quarterly revenue year-on-year change?
- What is Verve Therapeutics TTM revenue?
- What is the all time high TTM revenue for Verve Therapeutics?
- What is Verve Therapeutics TTM revenue year-on-year change?
What is Verve Therapeutics annual revenue?
The current annual revenue of VERV is $11.76 M
What is the all time high annual revenue for Verve Therapeutics?
Verve Therapeutics all-time high annual revenue is $11.76 M
What is Verve Therapeutics annual revenue year-on-year change?
Over the past year, VERV annual revenue has changed by +$9.82 M (+505.77%)
What is Verve Therapeutics quarterly revenue?
The current quarterly revenue of VERV is $6.87 M
What is the all time high quarterly revenue for Verve Therapeutics?
Verve Therapeutics all-time high quarterly revenue is $6.87 M
What is Verve Therapeutics quarterly revenue year-on-year change?
Over the past year, VERV quarterly revenue has changed by +$3.75 M (+120.24%)
What is Verve Therapeutics TTM revenue?
The current TTM revenue of VERV is $24.40 M
What is the all time high TTM revenue for Verve Therapeutics?
Verve Therapeutics all-time high TTM revenue is $24.40 M
What is Verve Therapeutics TTM revenue year-on-year change?
Over the past year, VERV TTM revenue has changed by +$16.77 M (+219.91%)